Biostem Technologies Inc (BSEM)

$4.96 -0.09 (-1.84%)
Market Cap 83.12M
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 4.43
Forward PE 19.42
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 46,200
Avg Vol 76,646
Day's Range N/A - N/A
Shares Out 16.77M
Stochastic %K 63%
Beta -0.44
Analysts Strong Buy
Price Target $25.50

Company Profile

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding s...

Industry: Biotechnology
Sector: Healthcare
Phone: 954 380 8342
Address:
2836 Center Port Circle, Pompano Beach, United States
FinJay
FinJay Oct. 5 at 4:27 AM
$BSEM https://youtu.be/Xav7hLwCVNQ
0 · Reply
Kewlpapa
Kewlpapa Oct. 2 at 1:52 AM
$BSEM got a starter here a few days ago. Big increase in volume today. Shares won’t be down here much longer
1 · Reply
Tungst10
Tungst10 Sep. 30 at 5:02 PM
# ⚡️ $BSEM TECHNICAL WATCH: BOUNCE POTENTIAL SETTING UP 📈 $BSEM is showing signs of strength as it continues to defend support levels.
1 · Reply
Tungst10
Tungst10 Sep. 30 at 3:00 PM
# 📢 $BSEM 11AM UPDATE: INSIDER CONFIDENCE + CATALYSTS IN PLAY ⚡️ **$BSEM** continues to draw attention into mid-day as the story builds
0 · Reply
Tungst10
Tungst10 Sep. 30 at 2:02 PM
# 🔔 $BSEM MID-MORNING UPDATE: MOMENTUM HOLDING STEADY 📊 **$BSEM** is holding firm after the open, showing strong relative strength and
0 · Reply
Tungst10
Tungst10 Sep. 30 at 1:30 PM
# 🚨 $BSEM ON WATCH: INSIDER BUYING + NASDAQ UPLISTING IN FOCUS 📈🔥 All eyes on **$BSEM** this morning as momentum builds on strong funda
0 · Reply
Benderama8
Benderama8 Sep. 28 at 2:45 PM
$BSEM This would be why the company isn't listing on Nasdaq anytime soon. They were recognizing revenue immediately upon transferring goods to their distributor instead of waiting for the distributor to make the sale, then recognizing revenue. They can do what they did, but they were supposed to record negative cash flow imo. Anyways, this is a mess and is will likely take some time for full restatement and auditor signoff. Might not see form 10 again for 6 months or more. https://www.otcmarkets.com/file/company/financial-report/496321/content
1 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:48 PM
$BSEM Hit new 52w low. So now needs to find a new bottom. Could have just occurred but who knows?
0 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:30 PM
$BSEM https://carolinefifemd.com/author/carolinefifemd/
0 · Reply
lostsailor0007
lostsailor0007 Sep. 25 at 7:06 PM
$BSEM Bottomed out today at $5.05 as their 6mo. Low from$9.99. Time to Buy in! But, will she go lower to $4.75, so I can in? Either way, looks like a great entry point!
1 · Reply
Latest News on BSEM
No data available.
FinJay
FinJay Oct. 5 at 4:27 AM
$BSEM https://youtu.be/Xav7hLwCVNQ
0 · Reply
Kewlpapa
Kewlpapa Oct. 2 at 1:52 AM
$BSEM got a starter here a few days ago. Big increase in volume today. Shares won’t be down here much longer
1 · Reply
Tungst10
Tungst10 Sep. 30 at 5:02 PM
# ⚡️ $BSEM TECHNICAL WATCH: BOUNCE POTENTIAL SETTING UP 📈 $BSEM is showing signs of strength as it continues to defend support levels.
1 · Reply
Tungst10
Tungst10 Sep. 30 at 3:00 PM
# 📢 $BSEM 11AM UPDATE: INSIDER CONFIDENCE + CATALYSTS IN PLAY ⚡️ **$BSEM** continues to draw attention into mid-day as the story builds
0 · Reply
Tungst10
Tungst10 Sep. 30 at 2:02 PM
# 🔔 $BSEM MID-MORNING UPDATE: MOMENTUM HOLDING STEADY 📊 **$BSEM** is holding firm after the open, showing strong relative strength and
0 · Reply
Tungst10
Tungst10 Sep. 30 at 1:30 PM
# 🚨 $BSEM ON WATCH: INSIDER BUYING + NASDAQ UPLISTING IN FOCUS 📈🔥 All eyes on **$BSEM** this morning as momentum builds on strong funda
0 · Reply
Benderama8
Benderama8 Sep. 28 at 2:45 PM
$BSEM This would be why the company isn't listing on Nasdaq anytime soon. They were recognizing revenue immediately upon transferring goods to their distributor instead of waiting for the distributor to make the sale, then recognizing revenue. They can do what they did, but they were supposed to record negative cash flow imo. Anyways, this is a mess and is will likely take some time for full restatement and auditor signoff. Might not see form 10 again for 6 months or more. https://www.otcmarkets.com/file/company/financial-report/496321/content
1 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:48 PM
$BSEM Hit new 52w low. So now needs to find a new bottom. Could have just occurred but who knows?
0 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:30 PM
$BSEM https://carolinefifemd.com/author/carolinefifemd/
0 · Reply
lostsailor0007
lostsailor0007 Sep. 25 at 7:06 PM
$BSEM Bottomed out today at $5.05 as their 6mo. Low from$9.99. Time to Buy in! But, will she go lower to $4.75, so I can in? Either way, looks like a great entry point!
1 · Reply
IRISHMIKE1
IRISHMIKE1 Sep. 24 at 4:07 PM
$BSEM Great update! Honestly the Nasdaq uplisting is taking way longer than it should with no update from company that makes sense. They only had to see what the company they were working with payments would be accounted on the books for Nasdaq. From last earnings that issue was resolved and still no uplisting to Nasdaq or real concise explanation why. I think until we get uplisting this is dead money. I got in this back in 2023. Yrs I am Green but thought last year was going to be the turning point then the uplisting and my 10,000 shares are just sitting there. Yes I doubled my money in 2 years but could have gotten out way higher but thought we would boom with uplisting but now just sitting down here waiting. Management needs to inform investors of realistic updates!!
0 · Reply
jcooptechit
jcooptechit Sep. 23 at 7:57 PM
$BSEM Regenerative Medicine Underdog with Major Catalysts Ahead! 🔹 Proprietary BioREtain technology preserves growth factors for advanced wound care 🔹 FDA-registered, AATB-accredited facility ensures high regulatory compliance 🔹 Expanding product line: VENDAJE, AmnioWrap2, VENDAJE OPTIC 🔹 Clinical trial for diabetic foot ulcers – topline results expected Q4 2025 🔹 Nasdaq uplisting in progress – could boost visibility & liquidity 🔹 Positioned for upside from CMS reimbursement changes in wound care 💥 With trial results + uplisting catalysts, BSEM could be setting up for a major breakout. Don’t sleep on this regenerative medicine play! Disclaimer: https://fh.bio/jcoop/
1 · Reply
Tungst10
Tungst10 Sep. 23 at 6:02 PM
🚨 $BSEM MIDDAY UPDATE: MOMENTUM STILL BUILDING 📊 $BSEM continues to trade steady as the $5 support zone holds strong — keeping this setu
0 · Reply
DiamondCapital
DiamondCapital Sep. 23 at 5:27 PM
$BSEM Add to watchlist - Quick DD https://x.com/stockpicksnyc/status/1970540002326016038?s=46 •Insane Revenue Growth $301M compared to $16M the year prior •NET PROFITABLE, high gross margins •Upcoming Clinical Catalysts Q4 2025 trial results expected •Recent insider purchase by CEO •Upcoming investor conferences •Proprietary BioREtain® technology •Strategic Acquisitions: ProgenaCare deal expanding product portfolio •And more Communicated disclaimer: https://tinyurl.com/u9uuyajs
0 · Reply
Tungst10
Tungst10 Sep. 23 at 3:30 PM
🚨 $BSEM RE-ALERT: TECHNICALS HOLDING STRONG 📈 $BSEM continues to set up well with its 10M float and clear technical reversal structure.
0 · Reply
jcooptechit
jcooptechit Sep. 23 at 3:22 PM
🚨 $BSEM Bullish Setup 🚨 BioStem Tech is consolidating above key support at $5.03 (DPOC) with a pivot at $5.11. * Support: $5.03 / $4.79 * Resistance: $5.60 → $6.20 → $7.60 * Breakout Watch: Over $5.60 short-term, $7.60 major breakout level Chart shows bullish accumulation – holding above $5.03 could fuel momentum with upside back toward $7.60+ 🔥 👉 Eyes on volume for confirmation. Disclaimer: https://fh.bio/jcoop/
0 · Reply
jcooptechit
jcooptechit Sep. 23 at 1:43 PM
$BSEM (OTC) It's bullish when a CEO keeps slapping the stock! BioStem Technologies, a MedTech innovator in placental-derived wound care solutions, just flashed a major bullish signal. ✅ CEO Jason Matuszewski doubled down on his conviction, personally purchasing 15,500 shares in August across multiple transactions, investing $100,000 of his own money. ✅ This isn’t just pocket change; ahe now holds a massive 1,145,362 shares, showing strong insider skin in the game. ✅ Multiple buys at increasing prices demonstrate sustained insider confidence and belief in long-term upside. When the CEO puts over $100K of personal capital on the line, you know something big is brewing. With strong insider ownership and a rapidly growing MedTech footprint, BSEM looks primed for its next move higher. Disclaimer: https://fh.bio/jcoop/
1 · Reply
Tungst10
Tungst10 Sep. 23 at 1:25 PM
🚨 $BSEM: TECHNICAL REVERSAL IN PLAY 📈 Very interesting setup unfolding on $BSEM (10M float). Technical Analysis Highlights: ⚡ Gap targ
1 · Reply
IRISHMIKE1
IRISHMIKE1 Sep. 17 at 1:30 PM
$BSEM I wish we got an update on what really is going on with the uplifting? The original reason mentioned in the delay was resolved with last earning and we should have gotten additional info on the uplifting. The drop in net earnings would not be a reason for the Nasdaq to not grant the uplifting!
1 · Reply
GlobalInsights
GlobalInsights Sep. 17 at 11:44 AM
$BSEM https://oig.hhs.gov/documents/evaluation/10939/OEI-BL-24-00420.pdf
0 · Reply
GlobalInsights
GlobalInsights Sep. 15 at 6:50 PM
$BSEM https://carolinefifemd.com/2025/09/15/skin-substitute-payment-reform/
0 · Reply
uncScrooge
uncScrooge Sep. 12 at 2:39 PM
$BSEM I share the sentiment most seem to have that management should be much more transparent so that investors can make better decisions. However, lacking information, my gut feeling is that better news is on the horizon and I am now starting to buy back stocks.
2 · Reply